Related Experiment Video
Updated: May 13, 2026
13:47
Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Glaucoma severity and medication adherence in a county hospital population
Cindy Ung1, Elisa Zhang, Tatyana Alfaro
1Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
Ophthalmology
|March 5, 2013
Summary
Patients with severe glaucoma are more likely to adhere to their eye pressure-lowering medications. This study found that milder glaucoma disease was associated with lower medication adherence rates.
Area of Science:
- Ophthalmology
- Public Health
Background:
- Glaucoma is a leading cause of irreversible blindness worldwide.
- Adherence to topical intraocular pressure (IOP)-lowering medications is crucial for managing glaucoma and preventing vision loss.
- Understanding factors influencing medication adherence is vital for effective glaucoma management.
Purpose of the Study:
- To investigate the association between glaucoma disease severity and medication adherence.
- To identify potential disparities in adherence among glaucoma patients in a county hospital setting.
Main Methods:
- A cross-sectional study was conducted with 126 glaucoma patients at a county hospital ophthalmology clinic.
- Disease severity was classified using American Academy of Ophthalmology guidelines.
- Medication adherence was assessed retrospectively over 18 months using pharmacy refill data and calculating the medication possession ratio (MPR >80% considered adherent).
Main Results:
- Patients with mild or moderate glaucoma were significantly more likely to be nonadherent compared to those with severe glaucoma (adjusted OR, 1.54; 95% CI, 1.03-2.31; P = 0.04).
- No statistically significant associations were found between adherence and age, gender, race, education, years with glaucoma, or number of medications.
- These findings suggest disease severity is a key factor in glaucoma medication adherence.
Conclusions:
- Severe glaucoma patients demonstrated higher adherence rates to topical IOP-lowering medications.
- Milder glaucomatous disease may be associated with challenges in maintaining consistent medication adherence.
- Further research may explore interventions to improve adherence in patients with less severe glaucoma.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...